Step by Step

INTRODUCTION

10/22/24 - Medical Grand Rounds: Forty Years of Forging Ahead: The History and Impact of the Pittsburgh Multicenter AIDS Cohort Study

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Define the "unknowns of HIV" and how it impacted the community
  • Explain your experience regarding HIV research and identifying the findings
  • Define the prognosis & treatments for HIV

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

    Suggested Additional Reading:
    • UNAIDS/WHO estimates, 2024
    • Wafaa El-Sadr, Columbia University and Harlem Hospital NY, NEJM 2006


    Joint Accreditation Statement

    In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Physician (CME)

    The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™.Each physician should only claim credit commensurate with the extent of their participation in the activity.


    Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Authors:
Bernard Macatangay, MD — Chief, Division of Infectious Diseases; Associate Professor of Medicine, University of Pittsburgh School of Medicine
Dr. Macatangay has disclosed he receives grant/research support from Astra Zeneca and Merck.
Charles Rinaldo, PhD — Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Deborah McMahon, MD — Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
John Mellors, MD — Distinguished Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine
Dr. Mellors receives grant/research support and is a consultant with Gilead Sciences, Inc. He is an Advisory Board Member for Gilead Sciences, Inc. and Infectious Diseases Connect, Inc. He has mutual share options in Galapagos, NV; Infectious Diseases Connect, Inc.; and, MingMed Biotechnology, Co., Ltd.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.